Table 3.

Impact of Non‐Invasive CMR Assessment on Patient Management

Impact of INCA (Peru)
All patients	98 (100%)
New diagnosis
Completely new diagnosis not suspected before (%)	19 (19%)
Therapeutic consequences
Change/addition in medication (%)	23 (23%)
Intervention/surgery (%)	6 (6%)
Invasive angiography/biopsy (%)	4 (4%)
Hospital discharge/admission (%)	3 (3%)
Impact on patient management (%) (new diagnosis and therapeutic consequences)	55 (56%)
Non‐invasive imaging ordered after CMR
Transthoracic—transesophageal echocardiogram (%)	6 (6%)
Cardiac computed tomography (%)	3 (3%)

CMR indicates cardiac magnetic resonance; INCA; Impact of Non‐Invasive CMR Assessment.